|
TBL3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.27699999999498E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.76690000040092E-07 |
| Normal-vs-Stage2 |
9.136400E-02 |
| Normal-vs-Stage3 |
3.421600E-03 |
| Normal-vs-Stage4 |
9.246500E-04 |
| Stage1-vs-Stage2 |
2.659000E-01 |
| Stage1-vs-Stage3 |
1.049150E-01 |
| Stage1-vs-Stage4 |
3.736800E-01 |
| Stage2-vs-Stage3 |
9.500800E-01 |
| Stage2-vs-Stage4 |
6.648600E-01 |
| Stage3-vs-Stage4 |
5.584000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.47300000000883E-05 |
| Normal-vs-AfricanAmerican |
3.77800002393514E-09 |
| Normal-vs-Asian |
2.202200E-01 |
| Caucasian-vs-AfricanAmerican |
1.92665999999564E-05 |
| Caucasian-vs-Asian |
8.712000E-01 |
| AfricanAmerican-vs-Asian |
7.220200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.840300E-04 |
| Normal-vs-Female |
4.30590000322084E-08 |
| Male-vs-Female |
1.279870E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.606160E-01 |
| Normal-vs-Age(41-60Yrs) |
1.84828999999498E-05 |
| Normal-vs-Age(61-80Yrs) |
6.45069999999359E-05 |
| Normal-vs-Age(81-100Yrs) |
3.337800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.611400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.478000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.207800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.652800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.213000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.770400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.51469999998266E-06 |
| Normal-vs-Grade 2 |
2.13149999999107E-05 |
| Normal-vs-Grade 3 |
7.8722000000031E-05 |
| Normal-vs-Grade 4 |
2.983700E-02 |
| Grade 1-vs-Grade 2 |
1.136020E-01 |
| Grade 1-vs-Grade 3 |
2.320100E-02 |
| Grade 1-vs-Grade 4 |
1.301780E-03 |
| Grade 2-vs-Grade 3 |
4.964600E-01 |
| Grade 2-vs-Grade 4 |
5.914100E-02 |
| Grade 3-vs-Grade 4 |
1.597020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.83040000000445E-05 |
| Normal-vs-ccB subtype |
3.495200E-01 |
| ccA subtype-vs-ccB subtype |
2.237700E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.968100E-04 |
| Normal-vs-N1 |
3.280000E-02 |
| N0-vs-N1 |
8.600800E-01 |
|
|
